Cancerrisiko ved topikale immunmodulatorer

Mette Deleuran; Claus Zachariae; Kristian Thestrup-Pedersen

Cancerrisiko ved topikale immunmodulatorer

Translated title of the contribution: Topical immune modulation and risk of cancer

Mette Deleuran, Claus Zachariae, Kristian Thestrup-Pedersen

Dermatology and Allergy

2 Citations (Scopus)

Abstract

This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.

Translated title of the contribution	Topical immune modulation and risk of cancer
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	171
Issue number	35
Pages (from-to)	2468-71
Number of pages	4
ISSN	0041-5782
Publication status	Published - 24 Aug 2009

Cite this

@article{622d4fe6c56146d6ae231ef27b69d6cd,

title = "Cancerrisiko ved topikale immunmodulatorer",

abstract = "This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.",

keywords = "Administration, Topical, Adult, Child, Dermatitis, Atopic, Humans, Immunosuppressive Agents, Lymphoma, Risk Factors, Skin Neoplasms, Tacrolimus",

author = "Mette Deleuran and Claus Zachariae and Kristian Thestrup-Pedersen",

year = "2009",

month = aug,

day = "24",

language = "Dansk",

volume = "171",

pages = "2468--71",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "35",

}

TY - JOUR

T1 - Cancerrisiko ved topikale immunmodulatorer

AU - Deleuran, Mette

AU - Zachariae, Claus

AU - Thestrup-Pedersen, Kristian

PY - 2009/8/24

Y1 - 2009/8/24

N2 - This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.

AB - This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.

KW - Administration, Topical

KW - Adult

KW - Child

KW - Dermatitis, Atopic

KW - Humans

KW - Immunosuppressive Agents

KW - Lymphoma

KW - Risk Factors

KW - Skin Neoplasms

KW - Tacrolimus

UR - https://www.scopus.com/pages/publications/70349239515

M3 - Tidsskriftartikel

C2 - 19732533

SN - 0041-5782

VL - 171

SP - 2468

EP - 2471

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 35

ER -

Cancerrisiko ved topikale immunmodulatorer

Abstract

Other files and links

Fingerprint

Cite this